A Randomized Comparison of Intravenous Amrinone Versus Dobutamine in Older Patients with Decompensated Congestive Heart Failure

Keyphrases

• Older Patients 100%
• Congestive Heart Failure 100%
• Dobutamine 100%
• Randomized Comparison 100%
• Amrinone 100%
• Hemodynamic Effects 30%
• Cardiac Index 30%
• Stroke Volume Index 30%
• Pulmonary Capillary Wedge Pressure 20%
• Adverse Effects 10%
• Clinical Trials 10%
• High Incidence 10%
• Prospective Randomized Trial 10%
• Left Ventricular Function 10%
• New York Heart Association Class 10%
• Left Ventricular Ejection Fraction 10%
• Aging Effect 10%
• Contractile Dysfunction 10%
• Echocardiography 10%
• Ventricular Arrhythmia 10%
• Tachycardia 10%
• Inotropic Support 10%
• Invasive Hemodynamics 10%
• Transthoracic 10%
• Systemic Vascular Resistance 10%
• Medication Dosing 10%
• Coronary Care Unit 10%
• Ventricular Ectopy 10%
• American Geriatrics Society 10%
• Haemodynamic Data 10%
• University Teaching Hospital 10%
• Drug Infusion 10%
• Monitoring Support 10%
• Stroke Index 10%
• Wedge Pressure 10%

Medicine and Dentistry

• Congestive Heart Failure 100%
• Dobutamine 100%
• Amrinone 100%
• Hemodynamic 50%
• Stroke Volume 30%
• Infusion 20%
• Pulmonary Artery Occlusion Pressure 20%
• Clinical Trial 10%
• Apoplexy 10%
• New York Heart Association Class 10%
• Echocardiography 10%
• Heart Left Ventricle Ejection Fraction 10%
• Tachyarrhythmia 10%
• Geriatrics 10%
• Side Effect 10%
• Heart Ventricle Arrhythmia 10%
• Inotropism 10%
• Hemodynamic Monitoring 10%
• Systemic Vascular Resistance 10%
• Coronary Care Unit 10%
• Adverse Effect 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Congestive Heart Failure 100%
• Dobutamine 100%
• Amrinone 100%
• Cerebrovascular Accident 40%
• Clinical Trial 10%
• Side Effect 10%
• Tachycardia 10%
• Heart Ventricle Arrhythmia 10%